`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`
`
`Inter Partes Review No.: IPR2021-00881
`
`
`U.S. Patent No. 9,254,338 B2
`Filed: July 12, 2013
`Issued: February 9, 2016
`Inventor: George D. Yancopoulos
`
`Title: USE OF A VEGF ANTAGONIST TO TREAT
`ANGIOGENIC EYE DISORDERS
`
`
`DECLARATION OF ERIC R. HUNT
`IN SUPPORT OF MYLAN PHARMACEUTICALS INC.’S UNOPPOSED
`MOTION FOR PRO HAC VICE ADMISSION
`
`Mylan Exhibit 1101
`Mylan v. Regeneron, IPR2021-00881
`Page 1
`
`
`
`I, Eric R. Hunt, declare as follows:
`
`Case IPR2021-00881
`Patent 9,254,338 B2
`Declaration of Eric R. Hunt
`
`
`1.
`
`I am an experienced litigating attorney with more than fifteen (15) years
`
`of experience.
`
`2.
`
`I have been actively litigating patent cases for more than fifteen (15)
`
`years.
`
`3.
`
`I am a member in good standing of the Bar of the State of Illinois and
`
`the Minnesota Bar, and am also admitted to practice in the United States Court of
`
`Appeals for the Federal Circuit and the United States District Court for the Northern
`
`District of Illinois.
`
`4.
`
`I have never been suspended or disbarred from practice before any court
`
`or administrative body.
`
`5.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`6.
`
`I have had no sanctions or contempt citations imposed against me by
`
`any court or administrative body.
`
`7.
`
`I am familiar with the subject matter at issue in this proceeding. More
`
`specifically, I am familiar with the patent at issue in this proceeding—U.S. Patent
`
`No. 9,254,338 B2 (“the ’338 patent”). I am advising Mylan on patent matters
`
`relating to the subject matter claimed in the ’338 patent and have been involved in
`
`
`
`1
`
`Mylan Exhibit 1101
`Mylan v. Regeneron, IPR2021-00881
`Page 2
`
`
`
`Case IPR2021-00881
`Patent 9,254,338 B2
`Declaration of Eric R. Hunt
`
`the strategy and drafting of Mylan’s Petition for Inter Partes Review of the ’338
`
`patent, including all prior art raised therein.
`
`8.
`
`I have read and will comply with the Office Patent Trial Practice Guide
`
`and the Board’s Rules for Practice for Trials set forth in C.F.R. Part 42 – Trial
`
`Practice Before the Patent Trial and Appeal Board.
`
`9.
`
`I agree to be subject to the United States Patent and Trademark Office
`
`Rules of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq., and to
`
`disciplinary jurisdiction under 37 C.F.R. § 11.19.
`
`10.
`
`In the last three (3) years, I have not applied to appear pro hac vice in
`
`an inter partes review proceeding.
`
`11.
`
`I hereby declare that all statements made herein of my own knowledge
`
`are true; and further that these statements are made with the knowledge that willful
`
`false statements and the like so made are punishable by fine or imprisonment, or
`
`both, pursuant to 18 U.S.C. § 1001.
`
`
`
`
`
`
`
`2
`
`Mylan Exhibit 1101
`Mylan v. Regeneron, IPR2021-00881
`Page 3
`
`
`
`Case IPR2021-00881
`Patent 9,254,338 B2
`Declaration of Eric R. Hunt
`
`
`Respectfully Submitted,
`
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`/Eric R. Hunt /
`Eric R. Hunt
`6 West Hubbard Street
`Suite 500
`Chicago, IL 60654
`Telephone:
`(312) 222-6314
`Facsimile:
`(312) 843-6260
`ehunt@rmmslegal.com
`
`3
`
`Dated: April 20, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Mylan Exhibit 1101
`Mylan v. Regeneron, IPR2021-00881
`Page 4
`
`